Fluorotronics USA Inc.
Farid Menaa (Bsc. Eng., Bsc. Bio., Msc. Genetics, Master Gerontology/Geriatry, Ph.D. Radiation Oncology and Gerontology, three international post-doctoral terms, EMBA Entrepreneurship and MD candidate), is an experienced and skilled inter- and multi-disciplinary professional. Professor, Consultant, Researcher, Principal Investigator, Executive Director, Advisor, Editor, Reviewer, Event Organizer and Entrepreneur, he earned his degrees with high distinctions from prestigious universities and institutions.He Was selected as a NIH post-doctoral fellow in Oncology (San Diego, California, USA; 2004-2007). Then, he pursued his career in Dermatology, and Stem Cells as a DFG post-doctoral Fellow (Wuerzburg, Germany; 2007-2009). Subsequently, Dr. Menaa was promoted to Chief Scientific Officer and Executive Vice-President R&D at Fluorotronics, Inc. (CA, USA; 2009-2010), a nanotechnology and fluorine chemical company. Eventually, Dr. Menaa was appointed Principal Investigator in Hematology and Genomics as a FAPESP post-doctoral Fellow (São Paulo, Brazil; 2010-2012). He was recently nominated for “Who´s is Who in the World”. He authored more than 100 publications (including peer-reviewed ISI research and review articles, books, textbooks, book chapters, conference proceedings, patents), and is the recipient of several awards.
Oncology, Gerontology, Genetics, Nutrition, Fluorine Chemistry, Biochemistry, Cell and Molecular Biology, Stem cells, Pharmaceutical Sciences, Regenerative medicine, Personalized Medicine, Translational Medicine, Integrative Medicine, Pharmacy, Nanobiotechnology and Nanomedicine